Theda Kontis, MD
Facial Plastic Surgery · Baltimore, MDNPI 1558479394
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,836 of the $15,765 with a category attached, or 75.1%. 8 manufacturers reported payments, led by AbbVie at 55.1% of the total. Reporting peaked in 2023 at $7,872 and has fallen 95.0% since, to $397 in 2025.
Across 94 payments — averaging $167.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Galderma Laboratories, L.p.$5K
- Merz North America, Inc.$1K
- Medtronic$150
- Johnson & Johnson$139
- Integra Lifesciences Corporation$133
- plus $130 from 2 others
Across 21 payments — averaging $4586.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galderma Laboratories, L.p.$92K
- AbbVie$4K
What the payments were for
- Consulting fees$11,83675%
- Speaking & faculty fees$5003%
- Food & beverage$3,42922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $8,680 |
| Galderma Laboratories, L.p. | 34 | $5,127 |
| Merz North America, Inc. | 10 | $1,406 |
| Medtronic | 1 | $150 |
| Johnson & Johnson | 1 | $139 |
| Integra Lifesciences Corporation | 3 | $133 |
| Revance Therapeutics, Inc. | 5 | $120 |
| Apyx Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$637
- XEOMIN$217
- TRUMATCH$139
- MATRIXMANDIBLE$139
How this compares
Too few facial plastic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 54 | $586 |
| ValacyclovirValacyclovir Hcl | 21 | $519 |
| Cefadroxil | 29 | $104 |
| Azithromycin | 11 | $28 |
| Oxycodone Hcl | 14 | $28 |
| Ondansetron OdtOndansetron | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Baltimore
- Randolph CaponeBaltimore$44K
- Ira PapelBaltimore$6K
- Brandon WachalAnnapolis$4K
- Lee KleimanSeverna Park$4K
- Henry SandelAnnapolis$2K
- Jennifer PorterBethesda$2K
- Jigar SitaparaColumbia$1K
- Thong leEllicott City$539
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.